In 2014, a study at Seoul St Mary’s Hospital analyzed BRAF V600E alleles in predicting PTC progression, and a significant association between presence of extrathryoidal extension, absence of chronic lymphocytic thyroiditis, and increase in tumor size and presence of BRAF V600E mutation was demonstrated.7 This evidence concerns the gene BRAF and Hashimoto thyroiditis.